Prevalence of respiratory viruses among pilgrims in Saudi Arabia during the Hajj 2026: a cross-sectional study
Journal of Travel Medicine · 19.10.2026
DOI: 10.1093/jtm/taag093 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Journal of Travel Medicine, online erschienen am 19.10.2026. Verfasst von Najim Z Alshahrani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family and Community Medicine, College of Medicine, University of Jeddah, Jeddah 23218, Saudi Arabia. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University of Jeddah, Jeddah, Saudi Arabia.
Abstract (Originalsprache)
Background
Hajj is one of the world’s largest annual mass gatherings and provides favourable conditions for respiratory virus transmission because of intense crowding and extensive international travel. Contemporary post-pandemic molecular surveillance data remain limited. This study investigated the prevalence, determinants and characteristics of respiratory virus detections among pilgrims during the 2026 Hajj season.
Methods
A cross-sectional study was conducted among adult domestic and international pilgrims over an extended peri-Hajj period (before, during and after Hajj) in the year 2026. Participants completed a structured questionnaire and provided combined nasopharyngeal and oropharyngeal swab specimens for multiplex real-time reverse transcription polymerase chain reaction detection of common respiratory viruses. A subset of positive samples underwent genomic sequencing for viral subtype and variant characterization. Logistic regression was used to identify factors associated with laboratory-confirmed respiratory viral infection.
Results
Among 412 enrolled pilgrims across all 3 phases, 58 (14.1%) tested positive for at least 1 respiratory virus. The prevalence of viral detection was 6.7% pre-Hajj, 16.0% during Hajj and 21.4% post-Hajj. Influenza A was the predominant virus (34.5%), followed by rhinovirus (24.1%), severe acute respiratory syndrome coronavirus 2 (20.7%), respiratory syncytial virus (13.8%), adenovirus (5.2%) and seasonal human coronaviruses (1.7%). Diabetes mellitus, chronic lung disease and smoking were independently associated with increased odds of respiratory virus detection. Conversely, receipt of pre-travel health advice, influenza vaccination and regular facemask use were independently associated with reduced odds of respiratory virus detection.
Conclusions
Respiratory virus transmission remains an important public health concern during Hajj. Strengthening pre-travel health advice, promoting influenza vaccination and reinforcing personal preventive measures may reduce respiratory viral transmission during Hajj and other international mass gatherings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Family and Community Medicine, College of Medicine, University of Jeddah, Jeddah 23218, Saudi Arabia.
- College of Applied Medical Sciences, University of Jeddah, Jeddah 23218, Saudi Arabia.
- Children's Hospital Westmead Clinical School, Sydney Infectious Diseases Institute, University of Sydney, Westmead, Sydney, NSW 2145, Australia.
ORCID-Profile: Harunor Rashid
Förderung
- University of Jeddah, Jeddah, Saudi Arabia
Zitieren
APA
Alshahrani, N. Z., Albeshry, A. M., Awan, Z., & Rashid, H. (2026). Prevalence of respiratory viruses among pilgrims in Saudi Arabia during the Hajj 2026: a cross-sectional study. Journal of Travel Medicine. https://doi.org/10.1093/jtm/taag093
Vancouver
Alshahrani NZ, Albeshry AM, Awan Z, Rashid H. Prevalence of respiratory viruses among pilgrims in Saudi Arabia during the Hajj 2026: a cross-sectional study. Journal of Travel Medicine. 2026. doi:10.1093/jtm/taag093
BibTeX
@article{Alshahrani2026,
author = {Alshahrani, Najim Z and Albeshry, Abdulrahman M and Awan, Zuhier and Rashid, Harunor},
title = {Prevalence of respiratory viruses among pilgrims in Saudi Arabia during the Hajj 2026: a cross-sectional study},
journal = {Journal of Travel Medicine},
year = {2026},
doi = {10.1093/jtm/taag093}
}
EUVIMED